Purple Biotech (PPBT) Minority Interest (2017 - 2026)
Purple Biotech (PPBT) posted quarterly Minority Interest of -$58000.0 for Q1 2026, down 220.83% year-over-year from $48000.0 in Q1 2025, and down 5.45% quarter-over-quarter from -$55000.0 in Q4 2025.
Purple Biotech (PPBT) Minority Interest (2017 - 2026) Analysis & Trends
Purple Biotech (PPBT) has reported Minority Interest for 10 consecutive years, with -$58000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Minority Interest fell 220.83% year-over-year to -$58000.0; the TTM figure through Mar 2026 stood at -$58000.0 (down 220.83% YoY), while the FY2025 annual figure was -$55000.0, down 207.84% from the prior year.
- Minority Interest retreated to -$58000.0 in Q1 2026 per PPBT's latest filing, from -$55000.0 in the prior quarter.
- Across five years, Minority Interest topped out at $259000.0 in Q1 2022 and bottomed at -$58000.0 in Q1 2026.
- Historically, Minority Interest has averaged $98941.2 across 5 years, with a median of $71000.0 in 2024.
- Annual changes were most pronounced in 2022 — Minority Interest retreated 24.05% — and 2026, when it sank 220.83%.
- Purple Biotech's Minority Interest stood at $187000.0 in 2022, then sank by 51.87% to $90000.0 in 2023, then plunged by 43.33% to $51000.0 in 2024, then sank by 207.84% to -$55000.0 in 2025, then fell by 5.45% to -$58000.0 in 2026.
- Business Quant data shows PPBT's Minority Interest at -$58000.0 in Q1 2026, -$55000.0 in Q4 2025, and $42000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - |
| 10 | Purple Biotech | 127.07 | 127.07 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58,000.00 |
| Dec 31, 2025 | -55,000.00 |
| Sep 30, 2025 | 42,000.00 |
| Jun 30, 2025 | 44,000.00 |
| Mar 31, 2025 | 48,000.00 |
| Dec 31, 2024 | 51,000.00 |
| Sep 30, 2024 | 56,000.00 |
| Jun 30, 2024 | 61,000.00 |
| Mar 31, 2024 | 71,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Sep 30, 2023 | 121,000.00 |
| Jun 30, 2023 | 140,000.00 |
| Mar 31, 2023 | 162,000.00 |
| Dec 31, 2022 | 187,000.00 |
| Sep 30, 2022 | 219,000.00 |
| Jun 30, 2022 | 244,000.00 |
| Mar 31, 2022 | 259,000.00 |
| Dec 31, 2021 | 279,000.00 |
| Sep 30, 2021 | 313,000.00 |
| Jun 30, 2021 | 325,000.00 |